KCNH2 Gene Short QT Syndrome Type 1 Genetic Test sale cost 4400 AED
MKKS Gene McKusick-Kaufman syndrome Genetic Test sale cost 4400 AED MKKS Gene McKusick-Kaufman syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CASQ2 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 2 Genetic Test sale cost 4400 AED CASQ2 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

KCNH2 Gene Short QT Syndrome Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KCNH2 Gene Short QT Syndrome Type 1 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the KCNH2 gene, which are associated with Short QT Syndrome Type 1 (SQTS1). SQTS1 is a rare genetic condition characterized by an abnormally short QT interval on an electrocardiogram (ECG), which can lead to life-threatening arrhythmias and sudden cardiac death. The KCNH2 gene plays a crucial role in the electrical activity of the heart, and mutations in this gene can disrupt the heart’s normal rhythm.

This genetic test involves collecting a DNA sample, typically through a blood draw or a cheek swab, and analyzing it for specific mutations in the KCNH2 gene. It is a critical tool for diagnosing SQTS1, allowing for appropriate management and treatment strategies to be implemented, potentially saving lives. The test is particularly recommended for individuals with a family history of Short QT Syndrome or unexplained sudden cardiac deaths.

At DNA Labs UAE, the cost of the KCNH2 Gene Short QT Syndrome Type 1 Genetic Test is 4400 AED. The testing process is conducted with high precision and confidentiality, ensuring patients receive accurate and reliable results. By opting for this test at DNA Labs UAE, individuals can take a proactive step towards understanding their genetic risk for SQTS1 and take necessary preventive measures to protect their heart health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNH2 Gene Short QT Syndrome Type 1 Genetic Test

Test Name: KCNH2 Gene Short QT Syndrome Type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for KCNH2 Gene Short QT Syndrome Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNH2 Gene Short QT Syndrome Type 1 NGS Genetic DNA Test gene KCNH2

Test Details

The KCNH2 gene is associated with a condition called Short QT Syndrome Type 1 (SQT1). SQT1 is a rare genetic disorder that affects the electrical system of the heart, leading to abnormally short QT intervals on an electrocardiogram (ECG). This can increase the risk of dangerous arrhythmias, such as ventricular fibrillation and sudden cardiac arrest.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of SQT1, NGS genetic testing can be used to identify mutations or variations in the KCNH2 gene that may be responsible for the condition.

The genetic test involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology, which can detect variations in the KCNH2 gene. The results of the test can help confirm a diagnosis of SQT1 and guide treatment decisions.

It is important to note that genetic testing for SQT1 and other genetic disorders should be conducted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can interpret the results and provide appropriate counseling and management recommendations.

Test Name KCNH2 Gene Short QT syndrome type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCNH2 Gene Short QT syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNH2 Gene Short QT syndrome type 1 NGS Genetic DNA Test gene KCNH2
Test Details

The KCNH2 gene is associated with a condition called Short QT syndrome type 1 (SQT1). SQT1 is a rare genetic disorder that affects the electrical system of the heart, leading to abnormally short QT intervals on an electrocardiogram (ECG). This can increase the risk of dangerous arrhythmias, such as ventricular fibrillation and sudden cardiac arrest.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of SQT1, NGS genetic testing can be used to identify mutations or variations in the KCNH2 gene that may be responsible for the condition.

The genetic test involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology, which can detect variations in the KCNH2 gene. The results of the test can help confirm a diagnosis of SQT1 and guide treatment decisions.

It is important to note that genetic testing for SQT1 and other genetic disorders should be conducted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can interpret the results and provide appropriate counseling and management recommendations.

SKU: TEST-3472 Category:

Related products